DK7783A - Fremgangsmaade til fremstilling af beta-lactamase-inhibitorer og kompositioner indeholdende saadanne, samt mellemprodukter for inhibitorerne - Google Patents

Fremgangsmaade til fremstilling af beta-lactamase-inhibitorer og kompositioner indeholdende saadanne, samt mellemprodukter for inhibitorerne Download PDF

Info

Publication number
DK7783A
DK7783A DK7783A DK7783A DK7783A DK 7783 A DK7783 A DK 7783A DK 7783 A DK7783 A DK 7783A DK 7783 A DK7783 A DK 7783A DK 7783 A DK7783 A DK 7783A
Authority
DK
Denmark
Prior art keywords
inhibitors
products
beta
procedure
preparation
Prior art date
Application number
DK7783A
Other languages
English (en)
Other versions
DK7783D0 (da
Inventor
Michael Stephen Kellogg
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK7783D0 publication Critical patent/DK7783D0/da
Publication of DK7783A publication Critical patent/DK7783A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK7783A 1982-01-11 1983-01-10 Fremgangsmaade til fremstilling af beta-lactamase-inhibitorer og kompositioner indeholdende saadanne, samt mellemprodukter for inhibitorerne DK7783A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33879482A 1982-01-11 1982-01-11

Publications (2)

Publication Number Publication Date
DK7783D0 DK7783D0 (da) 1983-01-10
DK7783A true DK7783A (da) 1983-07-12

Family

ID=23326196

Family Applications (1)

Application Number Title Priority Date Filing Date
DK7783A DK7783A (da) 1982-01-11 1983-01-10 Fremgangsmaade til fremstilling af beta-lactamase-inhibitorer og kompositioner indeholdende saadanne, samt mellemprodukter for inhibitorerne

Country Status (4)

Country Link
EP (1) EP0083977A1 (da)
JP (1) JPS58126890A (da)
DK (1) DK7783A (da)
GR (1) GR77151B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462934A (en) 1983-03-31 1984-07-31 Pfizer Inc. Bis-esters of dicarboxylic acids with amoxicillin and certain hydroxymethylpenicillanate 1,1-dioxides
US4503040A (en) * 1984-02-27 1985-03-05 Pfizer Inc. 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors
US4675186A (en) 1985-04-18 1987-06-23 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
ATE74359T1 (de) * 1987-01-27 1992-04-15 Pfizer 6-beta(substituierte)-(s)hydroxymethylpenicillans|ure und deren derivate.
US6395726B1 (en) 1999-01-26 2002-05-28 American Cyanamid Company 3,6-disubstituted penam sulfone derivatives
IL144116A0 (en) * 1999-01-26 2002-05-23 American Cyanamid Co 3,6-disubstituted penam sulfone derivatives as antibacterials

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598186A (en) * 1979-01-10 1980-07-25 Beecham Group Ltd Manufacture of penicillin derivative
DE2927004A1 (de) * 1979-07-04 1981-05-27 Bayer Ag, 5090 Leverkusen Penicillansaeure-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel als arzneimittel
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use

Also Published As

Publication number Publication date
JPS58126890A (ja) 1983-07-28
EP0083977A1 (en) 1983-07-20
DK7783D0 (da) 1983-01-10
GR77151B (da) 1984-09-07

Similar Documents

Publication Publication Date Title
DK159597C (da) Fremgangsmaade til formning af beholdere
DK619584D0 (da) Quinolonforbindelser, mellemprodukter til fremstilling af disse og praeparater indeholdende quinolonforbindelserne
DK267082A (da) Fremgangsmaade til fremstilling af et agglomereret, pulverformet maelkeprodukt
DK190281A (da) Fremgangsmaade til fremstilling af aminothiadiazoler
IT8348422A0 (it) Composti eterociclici, procedimento per prpararli e composizioni farmaceutiche che li contengono
AR231972A1 (es) Derivados de n-(ariloil o heteroariloil)-n-fenil-urea,composiciones plaguicidas que los contienen y procedimiento para la preparacion de dichos derivados
DK278284D0 (da) Substituerede lactam-derivater til anvendelse som angiotensinase- eller enkephalinase-inhibitorer og fremgangsmaade til fremstilling af saadanne derivater
DK94481A (da) Fremgangsmaade til fremstilling af pyridinonderivater
NO832610L (no) Derivater av morfolinyl-daunorubicin og morfolinyl-doxorubicin og analoge derav samt fremgangsmaate for fremstilling av disse
DK85585A (da) Fremgangsmaade til behandling af mejeribiprodukter
DK4283D0 (da) Fremgangsmade til fremstilling af formede foedevareprodukter
DK161482A (da) Fremgangsmaade til fremstilling af et analgetisk praeparat
DK160869C (da) Analogifremgangsmaade til fremstilling af substituerede urinstoffer og thiourinstoffer
NO159436C (no) Stabilisert beleggingsblanding og fremgangsmaate til belegging av glassbeholdere med tinnoksid.
DK298584D0 (da) 2-sulfamoylbenzo(b)thiophenderivat og ophthalmisk praeparat indeholdende en saadan forbindelse samt fremgangsmaade til fremstilling af forbindelsen
DK278684A (da) Substituerede sulfonylurinstofforbindelser, fremgangsmaade til fremstilling af disse forbindelser samt midler indeholdende disse med herbicid og plantevaekstregulerende virkning
DK489378A (da) 6-oxygenerede-3,20-dioxopregnanderivater samt fremgangsmaade til fremstilling der af og farmaceutiske kompositioner indeholdende disse
DK7783A (da) Fremgangsmaade til fremstilling af beta-lactamase-inhibitorer og kompositioner indeholdende saadanne, samt mellemprodukter for inhibitorerne
DK309282A (da) Fremgangsmaade til fremstilling af et analgetisk praeparat
DK307082A (da) Fremgangsmaade til forbedring af fosfatidprodukters fluiditetsegenskaber
DK423284D0 (da) Naphthalenylimidazopyridin og derivater heraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK144180A (da) Fremgangsmaade til fremstilling af betalactamaseinhibitorer
DK75683A (da) Fremgangsmaade til fremstilling af phosphorholdige antibiotiske forbindelser betegnet cl 1565-a, cl 1565-b og cl 1565-t
IT8422082A0 (it) Procedimento e composizioni per la colorazione di fanere.
DK185683D0 (da) Fremgangsmade til fremstilling af pleuromutilinderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment